Role of Y Box Protein-1 in cancer: As potential biomarker and novel therapeutic target
Pramod Kumar Maurya, Alok Mishra, Birendra Singh Yadav, Swati Singh, Prashant Kumar, Amit Chaudhary, Shweta Srivastava, Suriya Narayan Murugesan, Ashutosh Mani · Journal of Cancer · 2017
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
Journal of Cancer · Ivyspring International Publisher · review · 2017
Abstract
The Y-box binding protein (YB-1) is known to be a multifunctional transcription and translation factor during expression of several proteins.It is a vital oncoprotein that regulates cancer cell progression and proliferation.YB-1 is over-expressed in various human cancers such as breast cancer, colon cancer, lung cancer, gastric cancer, oesophageal cancer and glioblastoma.Nuclear expression of YB-1 is found to be associated with multidrug resistance and cancer cell progression.YB-1 is reported to regulate many cellular signalling pathways in different types of cancer proliferation.Knowledge about nuclear localization and nuclear level expression of YB-1 in different cancers has been correlated with prospective prognosis of cancer.This review discusses the prospects of YB-1 as a potential biomarker as well as therapeutic target in lieu of their role during cancer progression and multidrug resistance.
Open the resolved locator · 10.7150/jca.17689
Metadata licence: OpenAlex metadata (CC0)